CoreWeave vs Definium Therapeutics Inc. Common Shares — how do they compare? CoreWeave trades at $83.73 (market cap $44.99B), while Definium Therapeutics Inc. Common Shares trades at $35.59 (market cap $4.59B). The key difference: CoreWeave is far larger — about 9.8× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, CoreWeave nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold CoreWeave for 6 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| CRWV | DFTX | |
|---|---|---|
Market Cap | $44.99B | $4.59B |
Volume | 41,993,776 | 2,103,937 |
Sector | Technology | Health |
52-Week High | $143.08 | $48.45 |
52-Week Low | $60.82 | $10.68 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $91.06B | $3.55B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CoreWeave provides cloud computing infrastructure designed for AI workloads. Its platform gives organizations access to large-scale GPU computing and cloud services for training and running AI models.
Read more on CRWV →Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →